TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event
NEO

NeoGenomics Inc

Healthcare · Diagnostics & Research

19.90$ +0.1% vs. previous close Closing price · As of: Sep 18, 2026

Statements

Cash Flow

NeoGenomics Inc (NEO) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at 5.2 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Cash Flow NEO
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
9.5 6.4 21 18 45 23 1.5 -27 -66 -2.0 7.0 5.2
5.6 7.1 23 23 22 30 36 53 69 73 73 68
0.7 3.5 5.4 6.4 7.0 10 10 22 25 25 33 41
3.1 5.2 21 26 7.0 11 13 -70 28
-0.5 -1.9 -21 -31 13 -32 -62 -4.6 -32 -25 -33 -32
3.8 2.2 7.5 14 14 20 29 64 31 29 41 27
-9.6 -75 -6.5 -14 -140 -20 -159 -632 0.5 77 13 -12
0.0 0.0 88 0.0 9.6
37 0.9 -55 2.6 -50 11 20 15 13
-7.9 58 25 -6.7 -2.0 -5.3 97 331 -0.8 0.0 0.0 -201
29 58 -26 -4.1 92 159 236 725 12 4.6 4.6 -200
29 -10 -11 0.3 -3.0 163 78 66 -54 79 25 -207
5.7 4.2 14 4.3 30 3.3 -28 -91 -97 -31 -34 -22

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?